Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Jul;37(7):1492–1496. doi: 10.1128/aac.37.7.1492

Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.

C Atzori 1, A Bruno 1, G Chichino 1, E Bombardelli 1, M Scaglia 1, M Ghione 1
PMCID: PMC188000  PMID: 8363381

Abstract

The sesquiterpene bilobalide, extracted from Ginkgo biloba leaves, was tested in vitro and in vivo for the ability to inhibit Pneumocystis carinii growth. Bilobalide was inhibitory to trophozoites cultured on human embryonic lung fibroblasts (HEL 299) at approximately the same concentration as trimethoprim plus sulfamethoxazole (lowest effective concentration, 50 micrograms of bilobalide per ml versus 9/45 microgram of trimethoprim-sulfamethoxazole per ml), inducing microscopically detectable morphological changes in the cytoplasm of the parasite. In pharmacologically immunosuppressed Sprague-Dawley rats transtracheally infected with a suspension of about 5 x 10(6) P. carinii trophozoites per ml, the daily intraperitoneal administration of bilobalide (10 mg/kg of body weight for 8 days) lowered the number of organisms by approximately 2 logs (that is, about 99%). There was no apparent toxicity either in uninfected HEL 299 feeder cells or in infected and uninfected animals. These studies suggest that the sesquiterpene bilobalide might be useful for therapy of and prophylaxis against P. carinii infections in humans.

Full text

PDF
1492

Images in this article

1494Image
on p.1494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anke H., Sterner O. Comparison of the antimicrobial and cytotoxic activities of twenty unsaturated sesquiterpene dialdehydes from plants and mushrooms. Planta Med. 1991 Aug;57(4):344–346. doi: 10.1055/s-2006-960114. [DOI] [PubMed] [Google Scholar]
  2. Attella M. J., Hoffman S. W., Stasio M. J., Stein D. G. Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats. Exp Neurol. 1989 Jul;105(1):62–71. doi: 10.1016/0014-4886(89)90172-6. [DOI] [PubMed] [Google Scholar]
  3. Balu N., Thomas J. V., Bhat S. V. Monoterpenic fragment analogues of aplasmomycin as potential antimalarial. J Med Chem. 1991 Sep;34(9):2821–2823. doi: 10.1021/jm00113a021. [DOI] [PubMed] [Google Scholar]
  4. Barth S. A., Inselmann G., Engemann R., Heidemann H. T. Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochem Pharmacol. 1991 May 15;41(10):1521–1526. doi: 10.1016/0006-2952(91)90570-u. [DOI] [PubMed] [Google Scholar]
  5. Bartlett M. S., Fishman J. A., Queener S. F., Durkin M. M., Jay M. A., Smith J. W. New rat model of Pneumocystis carinii infection. J Clin Microbiol. 1988 Jun;26(6):1100–1102. doi: 10.1128/jcm.26.6.1100-1102.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bartlett M. S., Smith J. W. Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev. 1991 Apr;4(2):137–149. doi: 10.1128/cmr.4.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bourguet-Kondracki M. L., Longeon A., Morel E., Guyot M. Sesquiterpene quinones as immunomodulating agents. Int J Immunopharmacol. 1991;13(4):393–399. doi: 10.1016/0192-0561(91)90009-v. [DOI] [PubMed] [Google Scholar]
  8. Braquet P., Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol. 1991 Apr;32(1-3):135–139. doi: 10.1016/0378-8741(91)90111-p. [DOI] [PubMed] [Google Scholar]
  9. Chiari E., de Oliveira A. B., Raslan D. S., Mesquita A. A., Tavares K. G. Screening in vitro of natural products against blood forms of Trypanosoma cruzi. Trans R Soc Trop Med Hyg. 1991 May-Jun;85(3):372–374. doi: 10.1016/0035-9203(91)90296-b. [DOI] [PubMed] [Google Scholar]
  10. De Tommasi N., Pizza C., Conti C., Orsi N., Stein M. L. Structure and in vitro antiviral activity of sesquiterpene glycosides from Calendula arvensis. J Nat Prod. 1990 Jul-Aug;53(4):830–835. doi: 10.1021/np50070a009. [DOI] [PubMed] [Google Scholar]
  11. Fernex M., Jaquet C., Mittelholzer M. L., Reber R., Stürchler D. Neue Medikamente für die Behandlung der Malaria tropica. Schweiz Rundsch Med Prax. 1991 Jan 22;80(4):67–71. [PubMed] [Google Scholar]
  12. Grässel E. Einfluss von Ginkgo-biloba-Extrakt auf die geistige Leistungsfähigkeit. Doppelblindstudie unter computerisierten Messbedingungen bei Patienten mit Zerebralinsuffizienz. Fortschr Med. 1992 Feb 20;110(5):73–76. [PubMed] [Google Scholar]
  13. Herbage D., Willems R., Flandin F. Evaluation de l'extrait de Ginkgo Biloba et de ses constituants sur la fibrillogénèse et la stabilité des fibrilles de collagène in vitro. Phlebologie. 1991 Nov-Dec;44(4):873–880. [PubMed] [Google Scholar]
  14. Itokawa H., Totsuka N., Nakahara K., Maezuru M., Takeya K., Kondo M., Inamatsu M., Morita H. A quantitative structure-activity relationship for antitumor activity of long-chain phenols from Ginkgo biloba L. Chem Pharm Bull (Tokyo) 1989 Jun;37(6):1619–1621. doi: 10.1248/cpb.37.1619. [DOI] [PubMed] [Google Scholar]
  15. Jung F., Mrowietz C., Kiesewetter H., Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung. 1990 May;40(5):589–593. [PubMed] [Google Scholar]
  16. Ke O. Y., Krug E. C., Marr J. J., Berens R. L. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother. 1990 Oct;34(10):1961–1965. doi: 10.1128/aac.34.10.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kleijnen J., Knipschild P. Ginkgo biloba. Lancet. 1992 Nov 7;340(8828):1136–1139. doi: 10.1016/0140-6736(92)93158-j. [DOI] [PubMed] [Google Scholar]
  18. Kurihara K., Wardlaw A. J., Moqbel R., Kay A. B. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. J Allergy Clin Immunol. 1989 Jan;83(1):83–90. doi: 10.1016/0091-6749(89)90480-6. [DOI] [PubMed] [Google Scholar]
  19. Költringer P., Eber O. Die kollageninduzierte Thrombozytenaggregation unter parenteraler Ginkgo-biloba-Therapie. Wien Med Wochenschr. 1989 Mar 15;139(5):92–94. [PubMed] [Google Scholar]
  20. Költringer P., Eber O., Klima G., Rothlauer W., Wakonig P., Langsteger W., Lind P. Die Mikrozirkulation unter parenteraler Ginkgo-biloba-Extrakt-Therapie. Wien Klin Wochenschr. 1989 Mar 17;101(6):198–200. [PubMed] [Google Scholar]
  21. Lee I. S., Hufford C. D. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther. 1990;48(3):345–355. doi: 10.1016/0163-7258(90)90053-5. [DOI] [PubMed] [Google Scholar]
  22. Limper A. H., Martin W. J., 2nd Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest. 1990 Feb;85(2):391–396. doi: 10.1172/JCI114451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Long E. G., Smith J. S., Meier J. L. Attachment of Pneumocystis carinii to rat pneumocytes. Lab Invest. 1986 Jun;54(6):609–615. [PubMed] [Google Scholar]
  24. Merali S., Meshnick S. R. Susceptibility of Pneumocystis carinii to artemisinin in vitro. Antimicrob Agents Chemother. 1991 Jun;35(6):1225–1227. doi: 10.1128/aac.35.6.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pincemail J., Dupuis M., Nasr C., Hans P., Haag-Berrurier M., Anton R., Deby C. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia. 1989 Aug 15;45(8):708–712. doi: 10.1007/BF01974564. [DOI] [PubMed] [Google Scholar]
  26. Porsolt R. D., Martin P., Lenègre A., Fromage S., Drieu K. Effects of an extract of Ginkgo Biloba (EGB 761) on "learned helplessness" and other models of stress in rodents. Pharmacol Biochem Behav. 1990 Aug;36(4):963–971. doi: 10.1016/0091-3057(90)90107-s. [DOI] [PubMed] [Google Scholar]
  27. Pottratz S. T., Martin W. J., 2nd Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest. 1990 Nov;86(5):1678–1683. doi: 10.1172/JCI114891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pottratz S. T., Martin W. J., 2nd Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest. 1990 Feb;85(2):351–356. doi: 10.1172/JCI114445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rai G. S., Shovlin C., Wesnes K. A. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin. 1991;12(6):350–355. doi: 10.1185/03007999109111504. [DOI] [PubMed] [Google Scholar]
  30. Ramassamy C., Clostre F., Christen Y., Costentin J. Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J Pharm Pharmacol. 1990 Nov;42(11):785–789. doi: 10.1111/j.2042-7158.1990.tb07021.x. [DOI] [PubMed] [Google Scholar]
  31. Szabo M. E., Droy-Lefaix M. T., Doly M., Braquet P. Free radical-mediated effects in reperfusion injury: a histologic study with superoxide dismutase and EGB 761 in rat retina. Ophthalmic Res. 1991;23(4):225–234. doi: 10.1159/000267107. [DOI] [PubMed] [Google Scholar]
  32. Takazawa H., Kashino S. Incarnal. A new antibacterial sesquiterpene from Basidiomycetes. Chem Pharm Bull (Tokyo) 1991 Mar;39(3):555–557. doi: 10.1248/cpb.39.555. [DOI] [PubMed] [Google Scholar]
  33. Tripathi R., Dutta G. P., Vishwakarma R. A. Gametocytocidal activity of the antimalarial alpha/beta arteether against Plasmodium cynomolgi B. Am J Trop Med Hyg. 1990 Dec;43(6):571–575. doi: 10.4269/ajtmh.1990.43.571. [DOI] [PubMed] [Google Scholar]
  34. Walzer P. D. Attachment of microbes to host cells: relevance of Pneumocystis carinii. Lab Invest. 1986 Jun;54(6):589–592. [PubMed] [Google Scholar]
  35. Warot D., Lacomblez L., Danjou P., Weiller E., Payan C., Puech A. J. Comparaison des effets d'extraits de Ginkgo biloba sur les performances psychomotrices et la mémoire chez le sujet sain. Therapie. 1991 Jan-Feb;46(1):33–36. [PubMed] [Google Scholar]
  36. Watanabe N., Yamagishi M., Mizutani T., Kondoh H., Omura S., Hanada K., Kushida K. CAF-603: a new antifungal carotane sesquiterpene. Isolation and structure elucidation. J Nat Prod. 1990 Sep-Oct;53(5):1176–1181. doi: 10.1021/np50071a006. [DOI] [PubMed] [Google Scholar]
  37. Wattiaux-de Coninck S., Thibaut C., Gonze M. M., Wattiaux R. Effet de l'extrait de Ginkgo biloba sur la stabilisation des lysosomes. Phlebologie. 1989 Nov-Dec;42(4):667–672. [PubMed] [Google Scholar]
  38. Wattiaux R., Dubois F., Wattiaux-De Coninck S. Effet de différents extraits de Ginkgo biloba sur la réponse des lysosomes aux radicaux libres et au choc osmotique. Phlebologie. 1990 Nov-Dec;43(4):753–761. [PubMed] [Google Scholar]
  39. Winter E. Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav. 1991 Jan;38(1):109–114. doi: 10.1016/0091-3057(91)90597-u. [DOI] [PubMed] [Google Scholar]
  40. Zhang H., Xu L., Jin Q., Zhou L., Cheng P. [Anti-anaphylactic pharmacological action of water-soluble constituents of Ginkgo biloba L. episperm]. Zhongguo Zhong Yao Za Zhi. 1990 Aug;15(8):496-7, 513. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES